|
|
| Forum |
 |
Actual details on reduced Lymphocytes count?
on Sun Dec 04, 2011 3:32 am
|
 |
6-month MRI is complete
on Sun Jul 24, 2011 5:53 pm
|
 |
Gilenya® shows positive clinical outcomes in new trial
on Thu Dec 15, 2011 1:41 am
|
 |
Novartis investigating death possibly linked to Gilenya
on Tue Dec 13, 2011 12:27 am
|
 |
Anger at NICE oral MS drug Gilenya decision
on Tue Dec 06, 2011 1:29 am
|
 |
Gilenya fails to win NICE backing in draft guidance
on Thu Dec 01, 2011 1:54 am
|
 |
Approved under PBS in Australia!
on Tue Jun 21, 2011 4:30 am
|
 |
Gilenya® shows up to 71% reduction in relapse rates
on Sun Oct 16, 2011 11:38 pm
|
 |
Gilenya, after Tysabri and CCSVI procedure
on Tue Jun 21, 2011 5:02 am
|
 |
First oral MS drug, Gilenya, rejected by NICE
on Fri Aug 05, 2011 1:36 am
|
 |
Japan approves Novartis’ oral MS drug Gilenya
on Wed Sep 28, 2011 1:09 am
|
 |
Switching from Tysabri to Gilenya
on Sat Jan 29, 2011 4:47 pm
|
 |
Gilenya, may increase risk of macular edema in some patients
on Mon Sep 12, 2011 2:40 am
|
 |
FDA approves sNDA for Novartis’ oral MS drug Gilenya
on Wed Aug 03, 2011 5:24 am
|
 |
Humble reminder
on Sun Mar 13, 2011 10:03 am
|
 |
Oman licenses world's first oral drug for Multiple Sclerosis
on Mon Jul 25, 2011 7:32 am
|
 |
First Dose
on Tue Jul 19, 2011 10:29 am
|
 |
Oral fingolimod (Gilenya) in relapsing MS
on Tue Jul 12, 2011 7:55 am
|
 |
NICE announces timelines for appraisal of Gilenya-fingolimod
on Mon Jul 11, 2011 7:51 am
|
 |
Appraisal of Gilenya® (fingolimod) by NICE begins
on Fri Jul 08, 2011 2:06 am
|
 |
UAE licenses world's first oral medication for MS
on Mon Jun 27, 2011 7:00 am
|
 |
Gilenya can only gain as Merck scraps rival oral MS drug
on Wed Jun 22, 2011 8:01 am
|
 |
Day #.... Highlights of the first few days
on Wed Feb 02, 2011 4:09 pm
|
 |
Comparison of Gilenya with Avonex in relapsing-remitting MS
on Thu May 19, 2011 3:32 am
|
 |
Cardiovascular effects of oral MS drug Gilenya transient
on Thu May 19, 2011 3:17 am
|